BIO-RAD LABORATORIES, INC. — Director's Dealing 2015

Sep 10, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2015-09-08

Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President, and CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-09-08	Bio-Rad B Common Stock	M	2400	—	Acquired	194563	Direct
2015-09-08	Bio-Rad B Common Stock	J	1255	—	Disposed	193308	Direct
2015-09-09	Bio-Rad A Common Stock	S	1255	$138.6016	Disposed	411252	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-09-08	Restricted Stock Units	$0	M	2400	Disposed		Bio-Rad B Common Stock (2400)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Bio-Rad B Common Stock	12486	Indirect
Bio-Rad B Common Stock	4060054	Indirect
Bio-Rad B Common Stock	13726	Indirect

Footnotes

F1: Shares of Class B common stock acquired on the vesting of restricted stock units.

F2: The reporting person elected to convert shares of Class B common stock into Class A common stock on a 1-for-1 basis.

F3: Sold by the issuer on behalf of the reporting person to satisfy certain tax obligations in connection with the vesting of restricted stock units, all in accordance with a restricted stock unit award agreement.

F4: The reporting person disclaims beneficial ownership of these shares.

F5: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F6: The shares are held by a limited partnership of which the reporting person is a limited partner.

F7: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock.

F8: The restricted stock units vest in five equal annual installments beginning September 8, 2011.